a public good project by the
Synthesis
Company
of California

© 2026

Barbara J. Flynn | doi.page

0 works0 citations0 h-index

Barbara J. Flynn

National Institutes of Health(US)National Institute of Allergy and Infectious Diseases(US)

Publications by Year

Research Areas

Malaria Research and Control, SARS-CoV-2 and COVID-19 Research, HIV Research and Treatment, Immunotherapy and Immune Responses, Mosquito-borne diseases and control

Most-Cited Works

→ Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major(2007)1,394 cited
→ Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates(2020)1,152 cited
→ Protection against malaria at 1 year and immune correlates following PfSPZ vaccination(2016)374 cited
→ HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+T cell responses in nonhuman primates(2005)329 cited
→ Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates(2021)323 cited
→ A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite(2018)306 cited
→

Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates

(2006)

273 cited

→ Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection(2017)251 cited

→ mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron(2022)225 cited

→ Immunization with HIV-1 Gag Protein Conjugated to a TLR7/8 Agonist Results in the Generation of HIV-1 Gag-Specific Th1 and CD8+ T Cell Responses(2005)187 cited